INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit

August 1, 2019 sandiegobiotech News Comments Off on INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit

LA JOLLA, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., co-founder and CEO, will present at the Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit, taking place in Boston from Aug. 5 through Aug. 9.

Related Articles

No Picture
News

Correction: INmune Bio, Inc. Announces Closing of $25 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Over-Allotment Option

July 20, 2020 sandiegobiotech News, Syndication Comments Off on Correction: INmune Bio, Inc. Announces Closing of $25 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Over-Allotment Option

LA JOLLA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, July 20th by INmune Bio, Inc. (NASDAQ: INMB) was incorrectly reported with below sentence: […]

No Picture
News

INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer?s Disease at 2019 Alzheimer?s Association International Conference (AAIC) Satellite Symposium

September 23, 2019 sandiegobiotech News Comments Off on INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer?s Disease at 2019 Alzheimer?s Association International Conference (AAIC) Satellite Symposium

LA JOLLA, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunotherapy company developing treatments which harness the patient?s innate immune system to fight disease, announced today that the company will be presentin… […]

No Picture
News

CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq?s MarketSite and Announces Presentation at World Immunotherapy Congress

September 24, 2019 sandiegobiotech News Comments Off on CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq?s MarketSite and Announces Presentation at World Immunotherapy Congress

La Jolla, CA., Sept. 24, 2019 (GLOBE NEWSWIRE) — ?INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founde… […]